DaVita Inc. ($DVA) Stock Forecast: Down 11.8% Today

What is DaVita Inc.?

DaVita HealthCare (DVA) is a company that offers kidney dialysis services and related healthcare services, known for its stability in the healthcare sector.

Why is DaVita Inc. going down?

DVA stock is down 11.8% on Oct 30, 2024 17:06

• The bearish trend in DVA's stock can be linked to the company's Q3 earnings falling short of expectations.
• Despite strong Dialysis patient service revenues, the overall performance did not meet projections, leading to a negative market response.
• Investors' reaction to the -6.16% earnings surprise and 1.29% revenue miss likely contributed to the stock price drop.
• Market movements indicate investor caution regarding DVA's future performance and their interest in how the company addresses the missed estimates in the upcoming quarters.

DVA Price Chart

DVA Technical Analysis

DVA News

DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up

DVA's robust Dialysis patient service revenues drives its third-quarter performance.

https://www.zacks.com/stock/news/2360908/davita-stock-declines-after-q3-earnings-miss-estimates-margins-up

DaVita HealthCare ( DVA ) Q3 Earnings Miss Estimates

DaVita HealthCare (DVA) delivered earnings and revenue surprises of -6.16% and 1.29%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2359954/davita-healthcare-dva-q3-earnings-miss-estimates

DVA Q3 Estimates Unchanged Before Earnings: How to Play the Stock?

Improvement in RPT is likely to have boosted DaVita's top line in the third quarter.

https://www.zacks.com/stock/news/2358007/dva-q3-estimates-unchanged-before-earnings-how-to-play-the-stock

DaVita HealthCare ( DVA ) Stock Moves -0.23%: What You Should Know

In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $162.78, denoting a -0.23% change from the preceding trading day.

https://www.zacks.com/stock/news/2356321/davita-healthcare-dva-stock-moves--023-what-you-should-know

Trending Today

Fantom ($FTM) Crypto Forecast: Up 5.3% Today

Curve DAO Token ($CRV) Crypto Forecast: Up 9.7% Today

Pepe ($PEPE) Crypto Forecast: Up 6.0% Today

Bitcoin ($BTC) Crypto Forecast: Up 5.6% Today

Shiba Inu ($SHIB) Crypto Forecast: Up 5.4% Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.2% Today

Avalanche ($AVAX) Crypto Forecast: Up 6.1% Today

Horizen ($ZEN) Crypto Forecast: Up 21.5% Today

Toncoin ($TON) Crypto Forecast: Up 5.2% Today

Memecoin ($MEME) Crypto Forecast: Up 5.1% Today

DaVita Inc. Price History

30.07.2024 - DVA Stock was down 2.7%

• The CFO and CEO of DaVita Inc. have recently sold a significant amount of company stock, totaling over $16 million, which could indicate a lack of confidence in the company's future performance.
• Insider selling can raise investor concerns about the company's prospects, leading to a negative sentiment in the market.
• The insider selling news may have contributed to a significant decline in DaVita's stock price today.
• Investors may view these insider sales as a warning sign and choose to sell their DaVita positions, causing the stock price to drop further.

30.09.2024 - DVA Stock was down 6.6%

• DaVita HealthCare (DVA) reported Q3 earnings that missed estimates by -6.16%, which could have contributed to the bearish movement.
• Despite an expected improvement in Revenue Per Treatment (RPT), the stock still experienced a negative change of -0.23%, possibly due to the earnings miss.
• Investors may be cautious about the future outlook of DVA, considering the earnings surprise and the slight decline in stock price.

30.09.2024 - DVA Stock was down 11.8%

• The bearish trend in DVA's stock can be linked to the company's Q3 earnings falling short of expectations.
• Despite strong Dialysis patient service revenues, the overall performance did not meet projections, leading to a negative market response.
• Investors' reaction to the -6.16% earnings surprise and 1.29% revenue miss likely contributed to the stock price drop.
• Market movements indicate investor caution regarding DVA's future performance and their interest in how the company addresses the missed estimates in the upcoming quarters.

12.08.2024 - DVA Stock was up 5.2%

• DaVita HealthCare (DVA) saw a bullish movement as the stock gained +0.29%.
• The company's focus on providing essential kidney care services in the US likely contributed to investor optimism.
• DaVita's intriguing valuation and its importance in societal health could have attracted investors looking for stable growth opportunities.
• The bullish trend in the stock reflects confidence in DaVita's business model and its position in the healthcare industry.

19.06.2024 - DVA Stock was down 5.1%

• DaVita's stock has been performing well year-to-date, gaining 29.8%, driven by strong fundamentals.
• The bearish movement today could be attributed to concerns over the company's reliance on commercial payers, which might have spooked investors.
• Despite the recent downturn, the long-term prospects for DaVita could still be positive given its solid fundamentals and market position.

05.02.2024 - DVA Stock was up 7.3%

• DaVita stock soared following positive news related to the kidney outcomes trial, FLOW, which demonstrated a significant reduction in kidney disease progression and mortality rates.
• The expansion of DaVita's international operations in Brazil, Colombia, and entry into Chile and Ecuador also contributed to the bullish sentiment.
• The positive developments in the dialysis sector, along with the company's strategic growth initiatives, likely fueled investor optimism and drove the stock higher.

24.04.2024 - DVA Stock was up 5.1%

• DaVita's shares surged by 34.5% year to date, outperforming the industry and the S&P 500 Composite.
• The company's strong momentum is driven by healthy fundamentals and growth opportunities in its Dialysis and related lab services.
• However, concerns about its dependence on commercial payers could be a potential risk factor for the stock in the future.
• The collaboration between Centene and Cityblock to enhance value-based care in Central Florida's Medicaid members could also have positively influenced investor sentiment towards DaVita, as it operates in a similar healthcare sector.

03.04.2024 - DVA Stock was down 5.3%

• The bearish movement in DaVita's stock today could be attributed to high-rolling investors positioning themselves bullish on the company.
• Despite DaVita's Q1 earnings and revenues surpassing estimates and showing improved margins, the market sentiment may have been influenced by other factors.
• The contrasting performance of DaVita's stock compared to Tandem Diabetes might have led to profit-taking or portfolio rebalancing by investors.
• The anticipation of a stock spinoff could have introduced uncertainty and volatility into DaVita's stock, impacting its price negatively.
• Investors might have gleaned additional insights into DaVita's performance and future outlook from the Q1 2024 earnings call, which could have influenced their trading decisions.

03.04.2024 - DVA Stock was down 5.7%

• The downward trend in DVA stock today can be attributed to the following factors:
• Exceeding Q1 2024 earnings and revenue estimates may not have met the market's high expectations.
• Anticipation of impending healthcare sector stock spinoffs may have prompted investors to reassess their DaVita holdings, leading to some selling activity.
• Varied market sentiments towards healthcare stocks, with one medical stock performing positively and another indicating a sell signal, could have impacted investor trust in DVA.
• General market conditions and investor attitudes towards healthcare firms likely contributed to the decline in DVA stock today.

15.06.2024 - DVA Stock was down 2.1%

• The unveiling of a novel kidney disease training curriculum by Dialysis Patient Citizens could have raised concerns among investors regarding potential future competition or industry changes that might impact DaVita HealthCare's market standing.
• Despite outperforming the S&P 500 in the latest trading session, the market's overall bearish trend, exemplified by the Dow's decline, potentially prompted investors to divest from DaVita HealthCare shares, contributing to the stock's downward trajectory.
• Investors might have opted to capitalize on the slight stock price increase, particularly amidst a volatile market environment characterized by uncertainties and rapid market fluctuations.

26.06.2024 - DVA Stock was down 4.0%

• DVA stock experienced a notable bearish movement following the company agreeing to pay $34.5 million for alleged kickbacks. This development could have triggered investor concerns, resulting in a sell-off.
• Amid the general market decline, DVA's legal issues and potential financial consequences outweighed any positive market shifts, leading to a significant stock drop.
• Investor apprehensions regarding how these legal challenges could affect DVA's reputation and financial performance contributed to a bearish outlook and a decline in the stock price.

07.07.2024 - DVA Stock was down 5.0%

• Despite exceeding Q2 earnings estimates and raising its income guidance for 2024, DaVita Inc. witnessed a decline in its stock price.
• This decrease could be linked to investors selling shares to capture profits or in response to expectations of even higher earnings and guidance.
• Potential concerns raised during the earnings call may have influenced investor confidence despite the positive financial results.
• The stock movement might also be influenced by general market conditions or specific challenges affecting the healthcare sector.